Therapeutics: Jumonji domain containing 1C (JMJD1C)

Mouse studies suggest inhibiting JMJD1C could help treat AML. In bone marrow and spleen leukemia-initiating stem cells from a mouse model of AML, levels of JMJD1C were higher than in bone marrow and s...